feed

S&P 500—

NASDAQ—

DOW—

VIX—

US10Y—

EUR/USD—

GOLD—

WTI—

BTC—

AArphraTerminal

Arphra/Issuer/VRTX

VRTX

Vertex Pharmaceuticals Incorporated

HealthcareBiotechnologyUSUSD

$438.40

+0.50%LiveJun 01, 2026

Market cap

$111.27B

52w range

362.50 – 507.92

P / E

—

EPS

—

Volume

1.11M

Revenue · FY

$12.07B

+9.57% YoY

Explain this page

Arphra AIPlain-English read on Vertex Pharmaceuticals Incorporated’s valuation

No ESG data on file

ESG disclosures for VRTX aren't available yet — check back shortly.

Browse the cross-market ESG hub instead.